Aug 16, 2022, 01:00 AM by User Not Found

Bio-IT World | Evidence is emerging that long COVID (formally “post-acute sequelae SARS-CoV-2 infection,” or PASC) bears a striking, molecular-level resemblance to the disabling and complex illness now known as myalgic encephalomyelitis/chronic fatigue syndrome.

Aug 15, 2022, 10:18 AM by

Saama announces multi-year agreement with Merck to integrate Life Science Analytics Cloud (LSAC) into clinical development systems to build Machine Learning-Powered Clinical data layer to strengthen and expedite pipeline progress.

Aug 12, 2022, 10:06 AM by

Aug 11, 2022, 09:19 AM by

Innovative software platform digitalizes and automates cell culture medium development operations at globally leading CDMO

Aug 11, 2022, 09:18 AM by

Basel-headquartered developer of advanced software solutions recognized for success in digitalization of the global biotech industry

Aug 11, 2022, 09:17 AM by

Aug 11, 2022, 01:00 AM by User Not Found

Bio-IT World | A multi-national team of clinicians and scientists has determined that the consensus molecular subtype (CMS) classification of colorectal cancer needs updating to better reflect the molecular underpinnings of the disease.

Aug 10, 2022, 09:34 AM by

The researchers concluded that automated analysis of EEG data is a promising way to stratify patients and track disease progression, while enabling better patient selection for clinical trials.

Aug 10, 2022, 09:32 AM by

Aug 10, 2022, 09:30 AM by

Aug 10, 2022, 01:00 AM by User Not Found

Bio-IT World | The International Organization for Standardization (ISO) has published Phenopackets, a standard initially developed by the Global Alliance for Genomics and Health and championed at ISO under the Canadian Mirror Committee to ISO/TC215/SC1 Genomics informatics, and supported by the Standards Council of Canada.

Aug 9, 2022, 10:34 AM by

Sapio Sciences releases a new version of their ELN and LIMS software complete with AI advancements.

Aug 9, 2022, 01:00 AM by User Not Found

Bio-IT World | Researchers in Germany have developed a web-based tool, powered by machine learning, which extracts disease subtypes from large pools of patient data. The goal is more precise and robust predictions about molecular signatures that can serve as a starting point for investigating disease heterogeneity.

Aug 8, 2022, 10:15 AM by

Cypex’s recombinant xenobiotic metabolizing enzymes complement BioIVT’s extensive portfolio of hepatocytes and related hepatic products for drug research and development.

Aug 8, 2022, 10:14 AM by

The newly announced agenda for Connect in Pharma focuses on innovation as the foundation of a strong pharmaceutical industry in Europe. In order to ensure a strong future for European pharma, businesses need to prioritise digitalisation and maintain control of production lines, say two speakers due to present at the Geneva-based event in September.

Aug 5, 2022, 09:14 AM by

Aug 5, 2022, 01:00 AM by User Not Found

Bio-IT World | Though advancements in instruments and software have driven life sciences breakthroughs that drastically improve global health outcomes, researchers still struggle to maximize the value of the huge datasets that these high-throughput technologies generate. Currently, two common practices stand in the way of good data management at many life sciences institutions.

Aug 4, 2022, 09:37 AM by

The charity Antibiotic Research UK welcomes Jonathan Pearce as the new CEO, effective 1 August 2022. He takes over the position from founder Professor Colin Garner, who retired at the end of July 2022.

Aug 4, 2022, 09:36 AM by

Aug 3, 2022, 09:36 AM by

BOC Sciences has been constantly enriching its peptide product library for years. Its peptides for diabetes research are recently brought into focus due to the growing concerns on this problem.